American National Bank & Trust (Virginia)’s AstraZeneca AZN Stock Holding History

American National Bank & Trust (Virginia)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$429K	Buy	+3,168	New	+$419K	0.1%	107

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American National Bank & Trust (Virginia)'s AZN Position: Q1 2024 in Review

American National Bank & Trust (Virginia) opened a new position in AstraZeneca (AZN) in Q1 2024: 3,168 shares worth $429K. The stake represents 0.1% of the portfolio and ranks #107 among its holdings.

1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

American National Bank & Trust (Virginia) held 3,168 shares of AstraZeneca worth $429K as of Q1 2024.
AstraZeneca was a new American National Bank & Trust (Virginia) position in Q1 2024.
AstraZeneca made up 0.1% of American National Bank & Trust (Virginia)'s portfolio in Q1 2024, its #107 holding.
1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q1 2024, filed 19 Apr 2024.